BTIG Maintains Buy on Neuronetics, Raises Price Target to $6

Benzinga Newsdesk www.benzinga.com Positive 79.4%

Neg 0% Neu 0% Pos 79.4%

BTIG analyst Sam Eiber maintains Neuronetics (NASDAQ:STIM) with a Buy and raises the price target from $5 to $6.

Comments

No comments yet. Be the first!